via University of Waterloo
Researchers at the University of Waterloo are developing a DNA-based vaccine that can be delivered through a nasal spray.
The vaccine will work by using bacteriophage, a process that will allow the vaccine to replicate within bacteria already in the body and is being designed to target tissues in the nasal cavity and lower respiratory tract.
“When complete, our DNA-based vaccine will be administered non-invasively as a nasal spray that delivers nanomedicine engineered to immunize and decrease COVID-19 infections,” explains Roderick Slavcev, a professor in the School of Pharmacy who specializes in designing vaccines, pharmaceuticals and gene-therapy treatments. “This research combines the expertise of many and leverages existing technology developed by my team, which we’re reconfiguring for a COVID-19 application.”
When completed, the researchers aim to have the DNA-based vaccine enter cells in targeted tissues and cause them to produce a virus-like particle (VLP) that will stimulate an immune response in people.
The VLP will look similar to the structure of SARS-CoV-2 (the virus which causes COVID-19), but is harmless. This similarity will activate the body’s natural immune response to protect against viral infections comparable to the VLP, including SARS-CoV-2. It will also bind to receptors that SARS-CoV-2 would bind to, limiting the possible sites for transmission. By causing these changes in the body, the vaccine will build immunity against COVID-19 and decrease the severity of infections in progress – serving as both a therapeutic and a vaccine.
Every detail of the vaccine, from ensuring the bacteriophage target specific cells in the respiratory tract to creating a minimal VLP to impersonate SARS-CoV-2, is specifically engineered by the researchers and requires testing.
To achieve the design of such a complex project, Slavcev is teaming up with Emmanuel Ho, another professor at the School of Pharmacy, and Marc Aucoin, professor of chemical engineering. Ho’s team is designing the nanomedication that will be delivered by the nasal spray, which is currently being tested. Aucoin’s lab is constructing and purifying the VLP and boosting immunity following the initial administration of the therapeutic vaccine.
“It is the collaborative effort of our talented teams that makes this multidisciplinary project so feasible and necessarily efficient as a potential universal vaccine solution against SARS-CoV infections,” says Slavcev. “To practice science with such urgency alongside such talented colleagues and their students is not only immensely educational, it is extremely rewarding.”
Slavcev’s team has completed design of the bacteriophage delivery system and is currently modifying this system to apply to COVID-19. Additional design of components and further testing will take place later this year. Components of the research are supported by a grant from the Natural Sciences and Engineering Research Council of Canada.
Note: This research has not yet been peer-reviewed and is being released as part of UWaterloo’s commitment to help inform Canada’s COVID-19 response.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
DNA-based COVID-19 vaccine
- PharmaJet’s Needle-free System to Be Used in Australian Clinical COVID-19 Trialon October 6, 2020 at 7:22 am
PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Stratis® Needle-free Injection System will be used to deliver a vaccine against SARS-CoV-2 in a clinical ...
- Covid-19 vaccine tracker, Sept 29: US firm asked to delay coronavirus clinical trials, and answer questionson October 5, 2020 at 9:36 pm
The vaccine seeks to use the DNA of the novel coronavirus to trigger the immune response in human bodies. No DNA-based vaccine has ever been produced for any human disease. The company said it will ...
- Inovio drops appeal of injunction ruling in court battle over experimental Covid-19 vaccineon October 2, 2020 at 12:11 pm
The latest on Inovio Pharmaceuticals' legal battle with a former contract manufacturer over the Montco company's experimental Covid-19 vaccine.
- EU Begins 1st Rolling Review Of COVID-19 Vaccine, SLDB To Restart DMD Trial, ENLV Soars, TARA Abuzzon October 2, 2020 at 1:05 am
Today's Daily Dose brings you news about the first rolling review of a COVID-19 vaccine in the EU, reverse merger of privately held Chinook Therapeutics with Aduro, Enlivex Therapeutics' positive ...
- A COVID-19 vaccine may come without a needle, the latest vaccine to protect without jabbingon October 1, 2020 at 5:25 am
Vaccines that appear particularly suitable to needle-free technology are DNA-based ones, including a COVID-19 vaccine being developed in Australia. Needle-free vaccines are attractive as they ...
Go deeper with Google Headlines on:
DNA-based COVID-19 vaccine
Go deeper with Bing News on:
- Some states plan to vet Covid-19 vaccines themselves. Bad idea, experts say.on October 7, 2020 at 2:12 am
California and at least five other states have said they may independently vet any vaccines, but experts warn that could needlessly confuse the public.
- White House approves new COVID-19 vaccine standards after FDA publishes them anywayon October 7, 2020 at 1:51 am
The White House on Tuesday, in an apparent reversal, approved stringent new Food and Drug Administration guidelines for emergency use approval of a COVID-19 vaccine. The Trump administration was ...
- China's experimental COVID-19 vaccine appears safe - studyon October 7, 2020 at 12:20 am
A Chinese experimental coronavirus vaccine being developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences was shown to be safe in an early stage clinical trial, ...
- US Agency Wants 2 Months Safety Data Before Approving Covid-19 Vaccineon October 6, 2020 at 11:16 pm
The US Food and Drug Administration made public its guidance for issuing emergency approval for a Covid-19 vaccine on Tuesday, making it clear it wants to see follow-up two months after trial ...
- President Donald Trump says COVID-19 vaccines are coming 'momentarily.' Scientists say they're not.on October 6, 2020 at 9:09 pm
President Donald Trump said COVID-19 vaccines Are coming "momentarily." Doctors and scientists have repeatedly refuted that claim.